Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 246

    1.

    Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum.

    Ganssauge M, Wilhelm H, Bartz-Schmidt KU, Aisenbrey S.

    Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1707-10.PMID: 19916212 [PubMed - in process]Related articles

    2.

    Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin(R)) for treatment of angoid streaks in pseudoxanthoma elasticum.

    Ganssauge M, Wilhelm H, Bartz-Schmidt KU, Aisenbrey S.

    Graefes Arch Clin Exp Ophthalmol. 2009 Sep 10. [Epub ahead of print]PMID: 19789889 [PubMed - as supplied by publisher]Related articles

    3.

    Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.

    Suesskind D, Ulmer A, Schiebel U, Fierlbeck G, Spitzer B, Spitzer MS, Bartz-Schmidt KU, Grisanti S.

    Acta Ophthalmol. 2009 Sep 11. [Epub ahead of print]PMID: 19747222 [PubMed - as supplied by publisher]Related articles

    4.

    Macular pigment and fixation after macular translocation surgery.

    Reinhard J, Kanis MJ, Berendschot TT, Schön C, Gelisken F, Trauzettel-Klosinski S, Bartz-Schmidt KU, Zrenner E.

    Br J Ophthalmol. 2009 Aug 26. [Epub ahead of print]PMID: 19713197 [PubMed - as supplied by publisher]Related articles

    5.

    Ultrastructural analysis of the pigment dispersion syndrome in DBA/2J mice.

    Schraermeyer M, Schnichels S, Julien S, Heiduschka P, Bartz-Schmidt KU, Schraermeyer U.

    Graefes Arch Clin Exp Ophthalmol. 2009 Nov;247(11):1493-504. Epub 2009 Jul 30.PMID: 19641932 [PubMed - indexed for MEDLINE]Related articles

    6.

    The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Lüke J, Peters S, Wirtz N, Yörük E, Lüke C, Bartz-Schmidt KU, Grisanti S, Szurman P.

    Br J Ophthalmol. 2009 Oct;93(10):1396-400. Epub 2009 Jul 23.PMID: 19628500 [PubMed - indexed for MEDLINE]Related articles

    7.

    Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

    Ziemssen F, Grisanti S, Bartz-Schmidt KU, Spitzer MS.

    Drugs Aging. 2009;26(4):295-320. doi: 10.2165/00002512-200926040-00002. Review.PMID: 19476398 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cyclo-oxygenase-2 expression in photon-radiated and non-radiated uveal melanomas.

    Suesskind D, Paulsen F, Buchgeister M, Spitzer B, Rohrbach JM, Bartz-Schmidt KU, Spitzer MS.

    Acta Ophthalmol. 2009 Apr 23. [Epub ahead of print]PMID: 19432844 [PubMed - as supplied by publisher]Related articles

    9.

    Human anterior lens capsule as carrier matrix for cultivated human corneal endothelial cells.

    Yoeruek E, Saygili O, Spitzer MS, Tatar O, Bartz-Schmidt KU, Szurman P.

    Cornea. 2009 May;28(4):416-20.PMID: 19411960 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Intravitreal injections of medications in Germany. Contract situation and legal conditions]

    Ziemssen F, Wiedemann P, Kampik A, Holz F, Bartz-Schmidt KU.

    Ophthalmologe. 2009 May;106(5):465-70. German. PMID: 19408003 [PubMed - indexed for MEDLINE]Related articles

    11.

    Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization.

    Tatar O, Adam A, Shinoda K, Kaiserling E, Boeyden V, Claes C, Eckardt C, Eckert T, Pertile G, Scharioth GB, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S.

    Arch Ophthalmol. 2009 Mar;127(3):275-81.PMID: 19273790 [PubMed - indexed for MEDLINE]Related articles

    12.

    Clinicopathological correlation of 3 patterns of calcification in a hydrophilic acrylic intraocular lens.

    Neuhann IM, Neuhann TF, Szurman P, Koerner S, Rohrbach JM, Bartz-Schmidt KU.

    J Cataract Refract Surg. 2009 Mar;35(3):593-7.PMID: 19251156 [PubMed - indexed for MEDLINE]Related articles

    13.

    Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

    Lüke M, Ziemssen F, Völker M, Altpeter E, Beutel J, Besch D, Bartz-Schmidt KU, Gelisken F.

    Graefes Arch Clin Exp Ophthalmol. 2009 Jun;247(6):745-54. Epub 2009 Feb 12.PMID: 19214552 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Intraocular bevacizumab as palliative therapy in melanoma-metastasis-associated rubeotic secondary glaucoma]

    Jaissle GB, Ulmer A, Henke-Fahle S, Aisenbrey S, Fierlbeck G, Bartz-Schmidt KU, Szurman P.

    Klin Monbl Augenheilkd. 2009 Jan;226(1):70-2. Epub 2009 Jan 27. German. No abstract available. PMID: 19173168 [PubMed - indexed for MEDLINE]Related articles

    15.

    Virtual reality training improves wet-lab performance of capsulorhexis: results of a randomized, controlled study.

    Feudner EM, Engel C, Neuhann IM, Petermeier K, Bartz-Schmidt KU, Szurman P.

    Graefes Arch Clin Exp Ophthalmol. 2009 Jul;247(7):955-63. Epub 2009 Jan 27.PMID: 19172289 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: one-year results.

    Beutel J, Ziemssen F, Lüke M, Partsch M, Bartz-Schmidt KU; The Bevacizumab Study Group, Gelisken F.

    Int Ophthalmol. 2008 Dec 20. [Epub ahead of print]PMID: 19099203 [PubMed - as supplied by publisher]Related articles

    17.

    The distribution, release kinetics, and biocompatibility of triamcinolone injected and dispersed in silicone oil.

    Spitzer MS, Kaczmarek RT, Yoeruek E, Petermeier K, Wong D, Heimann H, Jaissle GB, Bartz-Schmidt KU, Szurman P.

    Invest Ophthalmol Vis Sci. 2009 May;50(5):2337-43. Epub 2008 Dec 20.PMID: 19098319 [PubMed - indexed for MEDLINE]Related articles

    18.

    Sodium hyaluronate gels as a drug-release system for corticosteroids: release kinetics and antiproliferative potential for glaucoma surgery.

    Spitzer MS, Yoeruek E, Kaczmarek RT, Sierra A, Aisenbrey S, Grisanti S, Bartz-Schmidt KU, Szurman P.

    Acta Ophthalmol. 2008 Dec;86(8):842-8.PMID: 19086928 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use.

    Yoeruek E, Spitzer MS, Saygili O, Tatar O, Biedermann T, Yoeruek E, Bartz-Schmidt KU, Szurman P.

    J Cataract Refract Surg. 2008 Dec;34(12):2139-45.PMID: 19027573 [PubMed - indexed for MEDLINE]Related articles

    20.

    [100 years University Eye Hospital Tübingen]

    Rohrbach JM, Szurman P, Bartz-Schmidt KU.

    Klin Monbl Augenheilkd. 2008 Nov;225(11):975-82. Epub 2008 Nov 17. German. No abstract available. PMID: 19016208 [PubMed - indexed for MEDLINE]Related articles

    21.

    Ocular surface squamous neoplasia as the first apparent manifestation of HIV infection in Malawi.

    Spitzer MS, Batumba NH, Chirambo T, Bartz-Schmidt KU, Kayange P, Kalua K, Szurman P.

    Clin Experiment Ophthalmol. 2008 Jul;36(5):422-5.PMID: 18939345 [PubMed - indexed for MEDLINE]Related articles

    22.

    Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation.

    Tatar O, Shinoda K, Kaiserling E, Claes C, Eckardt C, Eckert T, Pertile G, Boeyden V, Scharioth GB, Yoeruek E, Szurman P, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group, Grisanti S.

    Br J Ophthalmol. 2009 Feb;93(2):159-65. Epub 2008 Oct 6.PMID: 18838410 [PubMed - indexed for MEDLINE]Related articles

    23.

    [Vitreal-induced RPE cell traction. Investigation of pathological vitreous samples in an in vitro contraction model]

    Beutel J, Lüke M, Bartz-Schmidt KU, Grisanti S.

    Ophthalmologe. 2009 Oct;106(10):893-8. German. PMID: 18830601 [PubMed - in process]Related articles

    24.

    Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate.

    Küçükerdönmez C, Beutel J, Bartz-Schmidt KU, Gelisken F.

    Br J Ophthalmol. 2009 Feb;93(2):235-9. Epub 2008 Oct 1.PMID: 18829633 [PubMed - indexed for MEDLINE]Related articles

    25.

    [Localisation of bevacizumab in the monkey retina after an intravitreal injection of Avastin]

    Schraermeyer U, Heiduschka P, Bartz-Schmidt KU.

    Ophthalmologe. 2009 Jul;106(7):619-24. German. PMID: 18781309 [PubMed - indexed for MEDLINE]Related articles

    26.

    [The influence of the HIV pandemic on the incidence of malignant ocular tumours in Southern Malawi (Blantyre)]

    Spitzer MS, Chirambo T, Kayange P, Szurman P, Yoeruek E, Bartz-Schmidt KU, Batumba HN.

    Ophthalmologe. 2009 Sep;106(9):813-8. German. PMID: 18781308 [PubMed - in process]Related articles

    27.

    Efficacy of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in the rodent retina.

    Tura A, Schuettauf F, Monnier PP, Bartz-Schmidt KU, Henke-Fahle S.

    Invest Ophthalmol Vis Sci. 2009 Jan;50(1):452-61. Epub 2008 Aug 29.PMID: 18757509 [PubMed - indexed for MEDLINE]Related articles

    28.

    One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion.

    Jaissle GB, Leitritz M, Gelisken F, Ziemssen F, Bartz-Schmidt KU, Szurman P.

    Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):27-33. Epub 2008 Aug 12.PMID: 18696094 [PubMed - indexed for MEDLINE]Related articles

    29.

    Adrenergic regulation of cAMP/protein kinase A pathway in corneal epithelium and endothelium.

    Grueb M, Bartz-Schmidt KU, Rohrbach JM.

    Ophthalmic Res. 2008 Oct;40(6):322-8. Epub 2008 Aug 7.PMID: 18688175 [PubMed - indexed for MEDLINE]Related articles

    30.

    Extraocular surgery for implantation of an active subretinal visual prosthesis with external connections: feasibility and outcome in seven patients.

    Besch D, Sachs H, Szurman P, Gülicher D, Wilke R, Reinert S, Zrenner E, Bartz-Schmidt KU, Gekeler F.

    Br J Ophthalmol. 2008 Oct;92(10):1361-8. Epub 2008 Jul 28.PMID: 18662916 [PubMed - indexed for MEDLINE]Related articles

    31.

    Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.

    Ulmer A, Beutel J, Süsskind D, Hilgers RD, Ziemssen F, Lüke M, Röcken M, Rohrbach M, Fierlbeck G, Bartz-Schmidt KU, Grisanti S.

    Clin Cancer Res. 2008 Jul 15;14(14):4469-74.PMID: 18628461 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization.

    Tatar O, Yoeruek E, Szurman P, Bartz-Schmidt KU; Tübingen Bevacizumab Study Group, Adam A, Shinoda K, Eckardt C, Boeyden V, Claes C, Pertile G, Scharioth GB, Grisanti S.

    Arch Ophthalmol. 2008 Jun;126(6):782-90.PMID: 18541840 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Beutel J, Warga M, Grisanti S, Peters S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P.

    Exp Eye Res. 2008 Jul;87(1):22-9. Epub 2008 Apr 23.PMID: 18514644 [PubMed - indexed for MEDLINE]Related articles

    34.

    Intravitreal bevacizumab in postoperative pseudophakic cystoid macular edema: does it really work?

    Spitzer MS, Szurman P, Bartz-Schmidt KU.

    J Cataract Refract Surg. 2008 Jun;34(6):880; author reply 880-1. No abstract available. PMID: 18498977 [PubMed - indexed for MEDLINE]Related articles

    35.

    Suppression of melanoma-associated neoangiogenesis by bevacizumab.

    Jaissle GB, Ulmer A, Henke-Fahle S, Fierlbeck G, Bartz-Schmidt KU, Szurman P.

    Arch Dermatol. 2008 Apr;144(4):525-7.PMID: 18427047 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study.

    Ziemssen F, Zhu Q, Peters S, Grisanti S, El Wardani M, Szurman P, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group, Ziemssen T.

    Int Ophthalmol. 2009 Aug;29(4):213-24. Epub 2008 Apr 17.PMID: 18418553 [PubMed - indexed for MEDLINE]Related articles

    37.

    Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cells.

    Yoeruek E, Spitzer MS, Tatar O, Biedermann T, Grisanti S, Lüke M, Bartz-Schmidt KU, Szurman P.

    Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1392-7.PMID: 18385055 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Treatment of age-related macular degeneration: focus on ranibizumab.

    Spitzer MS, Ziemssen F, Bartz-Schmidt KU, Gelisken F, Szurman P.

    Clin Ophthalmol. 2008 Mar;2(1):1-14.PMID: 19668384 [PubMed - in process]Related articlesFree article

    39.

    Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization.

    Tatar O, Shinoda K, Kaiserling E, Pertile G, Eckardt C, Mohr A, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S.

    Arch Ophthalmol. 2008 Feb;126(2):193-9.PMID: 18268209 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    [Postoperative antibiotics after intravitreal injection?]

    Ziemssen F, Dietz K, Bartz-Schmidt KU.

    Ophthalmologe. 2008 Feb;105(2):180-1; author reply 181-2. German. No abstract available. PMID: 18256840 [PubMed - indexed for MEDLINE]Related articles

    41.

    Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration.

    Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU, Inhoffen W.

    Eye (Lond). 2009 Mar;23(3):694-702. Epub 2008 Feb 1.PMID: 18239678 [PubMed - in process]Related articles

    42.

    Immunohistochemical localisation of intravitreally injected bevacizumab in the anterior chamber angle, iris and ciliary body of the primate eye.

    Peters S, Heiduschka P, Julien S, Bartz-Schmidt KU, Schraermeyer U.

    Br J Ophthalmol. 2008 Apr;92(4):541-4. Epub 2008 Jan 22.PMID: 18211933 [PubMed - indexed for MEDLINE]Related articles

    43.

    [Primary pars plana vitrectomy. Techniques, indications, and results]

    Heimann H, Bartz-Schmidt KU, Bornfeld N, Weiss C, Hilgers RD, Foerster MH.

    Ophthalmologe. 2008 Jan;105(1):19-26. Review. German. PMID: 18210121 [PubMed - indexed for MEDLINE]Related articles

    44.

    UV-A induced oxidative stress is more prominent in naturally pigmented aged human RPE cells compared to non-pigmented human RPE cells independent of zinc treatment.

    Biesemeier A, Kokkinou D, Julien S, Heiduschka P, Berneburg M, Bartz-Schmidt KU, Schraermeyer U.

    J Photochem Photobiol B. 2008 Feb 27;90(2):113-20. Epub 2007 Dec 4.PMID: 18203614 [PubMed - indexed for MEDLINE]Related articles

    45.

    Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Beutel J, Lüke C, Grisanti S, Peters S, Jaissle GB, Bartz-Schmidt KU, Szurman P.

    Graefes Arch Clin Exp Ophthalmol. 2008 Jun;246(6):817-22. Epub 2008 Jan 16.PMID: 18197412 [PubMed - indexed for MEDLINE]Related articles

    46.

    Bevacizumab (avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult mice.

    Heiduschka P, Julien S, Hofmeister S, Bartz-Schmidt KU, Schraermeyer U.

    Retina. 2008 Jan;28(1):46-55.PMID: 18185137 [PubMed - indexed for MEDLINE]Related articles

    47.

    Melanin precursor 5,6-dihydroxyindol: protective effects and cytotoxicity on retinal cells in vitro and in vivo.

    Heiduschka P, Blitgen-Heinecke P, Tura A, Kokkinou D, Julien S, Hofmeister S, Bartz-Schmidt KU, Schraermeyer U.

    Toxicol Pathol. 2007;35(7):1030-8.PMID: 18098047 [PubMed - indexed for MEDLINE]Related articles

    48.

    Time-dependent effects on contrast sensitivity, near and distance acuity: difference in functional parameters? (Prospective, randomized pilot trial of photodynamic therapy versus full macular translocation).

    Ziemssen F, Lüke M, Bartz-Schmidt KU, Gelisken F.

    Graefes Arch Clin Exp Ophthalmol. 2008 May;246(5):653-9. Epub 2007 Dec 11.PMID: 18071731 [PubMed - indexed for MEDLINE]Related articles

    49.

    Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: a prospective randomized multicenter clinical study.

    Heimann H, Bartz-Schmidt KU, Bornfeld N, Weiss C, Hilgers RD, Foerster MH; Scleral Buckling versus Primary Vitrectomy in Rhegmatogenous Retinal Detachment Study Group.

    Ophthalmology. 2007 Dec;114(12):2142-54.PMID: 18054633 [PubMed - indexed for MEDLINE]Related articles

    50.

    Safety profile of a taurine containing irrigation solution (AcriProTect) in pars plana vitrectomy.

    Yoeruek E, Jägle H, Lüke M, Grisanti S, Warga M, Krott R, Spitzer MS, Tatar O, Bartz-Schmidt KU, Szurman P.

    Retina. 2007 Nov-Dec;27(9):1286-91.PMID: 18046239 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...